APLT Earnings — Applied Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
APLT — Applied Therapeutics, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.13
Market Cap$162.7M
P/E—
52W Range$0.29 – $10.62
About Applied Therapeutics, Inc. Common Stock
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
